In vitro and in vivo direct monitoring of miRNA-22 expression in isoproterenol-induced cardiac hypertrophy by bioluminescence imaging

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 41, Issue 5, 2014, Pages 972-984

  Tu, Yingfeng ^a   Wan, Lin ^a   Zhao, Dongliang ^a   Bu, Lihong ^a   Dong, Dandan ^a   Yin, Zheyu ^a   Cheng, Zhen ^b   Shen, Baozhong ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Bioluminescence imaging; Cardiac hypertrophy; Firefly luciferase; Gaussia luciferase; miRNA 22

Indexed keywords

ANTAGOMIR; ANTAGOMIR 22; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; FIREFLY LUCIFERASE; GAUSSIA LUCIFERASE; ISOPRENALINE; LUCIFERASE; MICRORNA; MICRORNA 1; MICRORNA 133A; MICRORNA 199A; MICRORNA 21; MICRORNA 214; MICRORNA 22; MICRORNA 23A; MICRORNA 24; MICRORNA 26A; MICRORNA 27; MICRORNA 499; MICRORNA 9; MYOSIN HEAVY CHAIN BETA; UNCLASSIFIED DRUG; GREEN FLUORESCENT PROTEIN; MIRN22 MICRORNA, MOUSE;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; HEART MUSCLE CELL; IN VITRO STUDY; IN VIVO STUDY; ISOPROTERENOL-INDUCED CARDIAC HYPERTROPHY; MALE; MOUSE; NONHUMAN; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSTHORACIC ECHOCARDIOGRAPHY; UPREGULATION; ANIMAL; CARDIOMEGALY; CHEMICALLY INDUCED; GENETICS; LUMINESCENCE; METABOLISM; PROCEDURES; TOXICITY; WHOLE BODY IMAGING;

ANIMALS; CARDIOMEGALY; GREEN FLUORESCENT PROTEINS; ISOPROTERENOL; LUCIFERASES, FIREFLY; LUMINESCENT MEASUREMENTS; MICE; MICRORNAS; WHOLE BODY IMAGING;

EID: 84899117379     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-013-2596-3     Document Type: Article

References (38)

1. Huang ZP, Chen J, Seok HY, Zhang Z, Kataoka M, Hu X, et al. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ Res 2013;112:1234-43. doi: 10.1161/CIRCRESAHA.112.300682.
2. Bourajjaj M, Armand AS, da Costa Martins PA, Weijts B, van der Nagel R, Heeneman S, et al. NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure. J Biol Chem 2008;283:22295-303. doi: 10.1074/jbc.M801296200.
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
4. Benfey PN. Molecular biology: microRNA is here to stay. Nature 2003;425:244-5. doi: 10.1038/425244a.
5. Zhao D, Tu Y, Wan L, Bu L, Huang T, Sun X, et al. In vivo monitoring of angiogenesis inhibition via down-regulation of mir-21 in a VEGFR2-luc murine breast cancer model using bioluminescent imaging. PLoS One 2013;8:e71472. doi: 10.1371/journal.pone.0071472.
6. Nagalingam RS, Sundaresan NR, Gupta MP, Geenen DL, Solaro RJ, Gupta M. A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling. J Biol Chem 2013;288:11216-32. doi: 10.1074/jbc.M112.442384.
7. Cheng Y, Zhu P, Yang J, Liu X, Dong S, Wang X, et al. Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res 2010;87:431-9. doi: 10.1093/cvr/cvq082.
8. Ganesan J, Ramanujam D, Sassi Y, Ahles A, Jentzsch C, Werfel S, et al. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors. Circulation 2013;127:2097-106. doi: 10.1161/CIRCULATIONAHA.112.000882.
9. Lok SI, van Mil A, Bovenschen N, van der Weide P, van Kuik J, van Wichen D, et al. Post-transcriptional regulation of alpha-1-antichymotrypsin by microRNA-137 in chronic heart failure and mechanical support. Circ Heart Fail 2013;6:853-61. doi: 10.1161/CIRCHEARTFAILURE.112.000255.
10. Knezevic I, Patel A, Sundaresan NR, Gupta MP, Solaro RJ, Nagalingam RS, et al. A novel cardiomyocyte-enriched microRNA, miR-378, targets insulin-like growth factor 1 receptor: implications in postnatal cardiac remodeling and cell survival. J Biol Chem 2012;287:12913-26. doi: 10.1074/jbc.M111.331751.
11. Yang KC, Ku YC, Lovett M, Nerbonne JM. Combined deep microRNA and mRNA sequencing identifies protective transcriptomal signature of enhanced PI3Kalpha signaling in cardiac hypertrophy. J Mol Cell Cardiol 2012;53:101-12. doi: 10.1016/j.yjmcc.2012.04.012.
12. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 2007;100:416-24. doi: 10.1161/01.RES.0000257913.42552.23.
13. Xu XD, Song XW, Li Q, Wang GK, Jing Q, Qin YW. Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy. J Cell Physiol 2012;227:1391-8. doi: 10.1002/jcp.22852.
14. Tu Y, Wan L, Bu L, Zhao D, Dong D, Huang T, et al. MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention. Cell Physiol Biochem 2013;31:997-1008. doi: 10.1159/000350117.
15. Belmont PJ, Chen WJ, Thuerauf DJ, Glembotski CC. Regulation of microRNA expression in the heart by the ATF6 branch of the ER stress response. J Mol Cell Cardiol 2012;52:1176-82. doi: 10.1016/j.yjmcc.2012.01.017.
16. Wang J, Xu R, Lin F, Zhang S, Zhang G, Hu S, et al. MicroRNA: novel regulators involved in the remodeling and reverse remodeling of the heart. Cardiology 2009;113:81-8. doi: 10.1159/000172616.
17. Li Q, Song XW, Zou J, Wang GK, Kremneva E, Li XQ, et al. Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy. J Cell Sci 2010;123:2444-52. doi: 10.1242/jcs.067165.
18. Wang J, Yang X. The function of miRNA in cardiac hypertrophy. Cell Mol Life Sci 2012;69:3561-70. doi: 10.1007/s00018-012-1126-y.
19. Ucar A, Gupta SK, Fiedler J, Erikci E, Kardasinski M, Batkai S, et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun 2012;3:1078. doi: 10.1038/ncomms2090.
20. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007;316:575-9. doi: 10.1126/science.1139089.
21. Lin Z, Murtaza I, Wang K, Jiao J, Gao J, Li PF. miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc Natl Acad Sci U S A 2009;106:12103-8.
22. Han M, Yang Z, Sayed D, He M, Gao S, Lin L, et al. GATA4 expression is primarily regulated via a miR-26b-dependent post-transcriptional mechanism during cardiac hypertrophy. Cardiovasc Res 2012;93:645-54. doi: 10.1093/cvr/cvs001.
23. Shieh JT, Huang Y, Gilmore J, Srivastava D. Elevated miR-499 levels blunt the cardiac stress response. PLoS One 2011;6:e19481. doi: 10.1371/journal.pone. 0019481.
24. Inoue Y, Kiryu S, Izawa K, Watanabe M, Tojo A, Ohtomo K. Comparison of subcutaneous and intraperitoneal injection of D-luciferin for in vivo bioluminescence imaging. Eur J Nucl Med Mol Imaging 2009;36:771-9. doi: 10.1007/s00259-008-1022-8.
25. Berger F, Paulmurugan R, Bhaumik S, Gambhir SS. Uptake kinetics and biodistribution of 14C-D-luciferin-a radiolabeled substrate for the firefly luciferase catalyzed bioluminescence reaction: impact on bioluminescence based reporter gene imaging. Eur J Nucl Med Mol Imaging 2008;35:2275-85. doi: 10.1007/s00259-008-0870-6.
26. do Hwang W, Jang SJ, Kim YH, Kim HJ, Shim IK, Jeong JM, et al. Real-time in vivo monitoring of viable stem cells implanted on biocompatible scaffolds. Eur J Nucl Med Mol Imaging 2008;35:1887-98. doi: 10.1007/s00259-008-0751-z.
27. Inoue Y, Sheng F, Kiryu S, Watanabe M, Ratanakanit H, Izawa K, et al. Gaussia luciferase for bioluminescence tumor monitoring in comparison with firefly luciferase. Mol Imaging 2011;10:377-85. doi: 10.2310/7290.2010.00057.
28. Kim HJ, Chung JK, do Hwang W, Lee DS, Kim S. In vivo imaging of miR-221 biogenesis in papillary thyroid carcinoma. Mol Imaging Biol 2009;11:71-8. doi: 10.1007/s11307-008-0188-6.
29. Lee JY, Kim S, do Hwang W, Jeong JM, Chung JK, Lee MC, et al. Development of a dual-luciferase reporter system for in vivo visualization of microRNA biogenesis and posttranscriptional regulation. J Nucl Med 2008;49:285-94.
30. Ko HY, do Hwang W, Lee DS, Kim S. A reporter gene imaging system for monitoring microRNA biogenesis. Nat Protoc 2009;4:1663-9. doi: 10.1038/nprot.2009.119.
31. Ko HY, Lee DS, Kim S. Noninvasive imaging of microRNA124a-mediated repression of the chromosome 14 ORF 24 gene during neurogenesis. FEBS J 2009;276:4854-65. doi: 10.1111/j.1742-4658.2009.07185.x.
32. Ko MH, Kim S, do Hwang W, Ko HY, Kim YH, Lee DS. Bioimaging of the unbalanced expression of microRNA9 and microRNA9* during the neuronal differentiation of P19 cells. FEBS J 2008;275:2605-16.
33. Wu JC, Sundaresan G, Iyer M, Gambhir SS. Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. Mol Ther 2001;4:297-306. doi: 10.1006/mthe.2001.0460.
34. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005;438:685-9. doi: 10.1038/nature04303.
35. Kenanova V, Barat B, Olafsen T, Chatziioannou A, Herschman HR, Braun J, et al. Recombinant carcinoembryonic antigen as a reporter gene for molecular imaging. Eur J Nucl Med Mol Imaging 2009;36:104-14. doi: 10.1007/s00259-008- 0921-z.
36. Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, Newman M, et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 2007;42:1137-41. doi: 10.1016/j.yjmcc.2007.04. 004.
37. Kelly M, Bagnall RD, Peverill RE, Donelan L, Corben L, Delatycki MB, et al. A polymorphic miR-155 binding site in AGTR1 is associated with cardiac hypertrophy in Friedreich ataxia. J Mol Cell Cardiol 2011;51:848-54. doi: 10.1016/j.yjmcc.2011.07.001.
38. Troy T, Jekic-McMullen D, Sambucetti L, Rice B. Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. Mol Imaging 2004;3:9-23. doi: 10.1162/153535004773861688.